Brief: Landos Biopharma Reports Third Quarter Results

Landos Biopharma

10/11/2022 13:18

Nov 10 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS BIOPHARMA REPORTS THIRD QUARTER 2022 RESULTS AND
PROVIDES
BUSINESS UPDATE
    * LANDOS BIOPHARMA INC - AS OF SEPTEMBER 30, HAD CASH, CASH
EQUIVALENTS, MARKETABLE SECURITIES OF $48.0 MILLION
    * LANDOS BIOPHARMA INC - CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES WILL BE SUFFICIENT TO FUND PLANNED OPERATIONS FOR AT
LEAST NEXT 12 MONTHS
    * LANDOS BIOPHARMA INC - QTRLY LOSS PER SHARE $0.20

Source text for Eikon:  ID:nGNX4gTWtm 
Further company coverage:  LABP.O 
 ((reuters.briefs@thomsonreuters.com;))